Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Immunotherapy

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy?

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

Blocking growth of tumour blood vessels could boost immunotherapy

Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

Training viruses to be cancer killers

Professor Len Seymour’s team, at the Cancer Research UK Oxford Centre, have been developing a cancer-killing virus called EnAd. They've installed 'cell CCTV' in their lab...

British Science Week: 10 of the biggest changes in cancer research over the last 20 years

This year’s British Science Week runs from 10th – 19th March, and the theme is ‘change’.

Scrambled DNA inside tumours might hinder cancer immunotherapy

Cancer treatments that harness the power of the immune system might be less effective in patients whose tumours carry incorrectly packaged DNA.

Immunotherapy drug extends lives of advanced lung cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.

NCRI Cancer Conference 2016: Day 4 – liver cancer, obesity, immunotherapy poo predictions and more

Read our final roundup from this year's NCRI Cancer Conference, including how bacteria in the gut could help predict if immunotherapy will work.

Weight loss condition provides clue to why some immunotherapy treatments fail

A weight loss condition frequently seen in cancer patients could provide answers as to why certain immunotherapy treatments fail in some patients.

Pages